{"id":305730,"date":"2019-11-20T18:00:17","date_gmt":"2019-11-21T02:00:17","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/11\/healthcare-news-roundup-7\/"},"modified":"2019-11-20T18:03:14","modified_gmt":"2019-11-21T02:03:14","slug":"%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e6%96%b0%e8%81%9e%e7%b2%be%e9%81%b8-10","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/11\/%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e6%96%b0%e8%81%9e%e7%b2%be%e9%81%b8-10\/","title":{"rendered":"\u91ab\u7642\u4fdd\u5065\u65b0\u805e\u7cbe\u9078"},"content":{"rendered":"<h2><strong>Cellectis<\/strong><strong>\u57fa\u56e0\u7de8\u8f2f\u5c08\u5229\u5728\u6b50\u6d32\u6709\u6548<\/strong><\/h2>\n<ul>\n<li>\u70ba\u4e86\u61c9\u5c0d\u6311\u6230\uff08\u53cd\u5c0d\u7a0b\u5e8f\uff09\uff0c\u6b50\u6d32\u5c08\u5229\u5c40\u7dad\u6301<a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=CLLS\">Cellectis\uff08NASDAQ\uff1aCLLS\uff09<\/a>\u5c08\u5229\u7684\u6709\u6548\u6027\u3002\u6b50\u6d32\u5c08\u5229EP3004337\u6db5\u84cb\u4e86\u4f7f\u7528CRISPR \/ Cas9\u57fa\u56e0\u7de8\u8f2f\u6280\u8853\u70ba\u514d\u75ab\u7642\u6cd5\u88fd\u5099T\u7d30\u80de\u7684\u65b9\u6cd5\u3002<\/li>\n<li>\u8a72\u5c08\u5229\u6709\u6548\u671f\u81f32034\u5e74\u3002<\/li>\n<\/ul>\n<h2><strong>\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6\u6572\u5b9a<\/strong><strong>Celgene<\/strong><strong>\u6536\u8cfc\u4ea4\u6613<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=BMY\"><strong>\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6\uff08<\/strong>NYSE\uff1aBMY\uff09<\/a>\u5df2\u4ee5\u73fe\u91d1\u3001\u666e\u901a\u80a1\u548c\u53ef\u4ea4\u6613\u7684\u6216\u6709\u50f9\u503c\u6b0a\u4ee5\u7e3d\u8a08$740\u5104\u6536\u8cfcCelgene\uff08NASDAQ\uff1aCELG\uff09\u3002<\/li>\n<\/ul>\n<h2><strong>FDA<\/strong><strong>\u6279\u51c6<\/strong><strong>Alnylam<\/strong><strong>\u7684<\/strong><strong>Givosiran<\/strong><strong>\u7528\u65bc<\/strong><strong>AHP<\/strong><\/h2>\n<ul>\n<li>\u5728\u512a\u5148\u5be9\u67e5\u72c0\u614b\u4e0b\uff0cFDA\u6279\u51c6\u4e86<a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=ALNY\">Alnylam Pharmaceuticals\uff08ALNY + 7.5%\uff09<\/a>\u7528\u65bc\u6025\u6027\u809d\u535f\u5549\u75c7\uff08AHP\uff09\u7684RNAi\u6cbb\u7642\u54c1\u724cGivlaari\u3002<\/li>\n<li>\u597d\u6d88\u606f\u5df2\u7d93\u50b3\u5230RNAi\u5ee0\u5546Ionis Pharmaceuticals\uff08IONS + 3.5%\uff09\u548cAkcea Therapeutics\uff08AKCA + 8.7%\uff09\u3002<\/li>\n<\/ul>\n<h2><strong>\u8afe\u83ef\u5728\u52a0\u62ff\u5927\u555f\u52d5\u4eba\u5de5\u667a\u80fd\u5408\u4f5c<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=NVS\">\u8afe\u83ef\uff08NVS + 0.2%\uff09<\/a>\u81f4\u529b\u65bc\u5229\u7528\u4eba\u5de5\u667a\u80fd\uff08AI\uff09\u4f86\u6539\u8b8a\u85e5\u7269\u7684\u767c\u73fe\u3001\u958b\u767c\u548c\u5546\u696d\u5316\u65b9\u5f0f\u3002\u8afe\u83ef\u52a0\u62ff\u5927\u5206\u516c\u53f8\u5df2\u8207\u9b41\u5317\u514b\u4eba\u5de5\u667a\u80fd\u5b78\u9662Mila\u9032\u884c\u4e86\u70ba\u671f\u4e09\u5e74\u7684\u5408\u4f5c\u3002<\/li>\n<li>\u52a0\u62ff\u5927\u8afe\u83ef\u88fd\u85e5\u516c\u53f8\u7e3d\u88c1\u514b\u88e1\u65af\u8482\u5b89\u00b7\u99ac\u8d6b\uff08Christian Macher\uff09\u8868\u793a\uff1a\u201c\u901a\u904e\u5728Mila\u958b\u5c55\u696d\u52d9\uff0c\u8afe\u83ef\u5c07\u80fd\u5920\u7a4d\u6975\u53c3\u8207\u5176\u7368\u7279\u7684\u3001\u5145\u6eff\u6d3b\u529b\u7684\u516c\u53f8\u3001\u7814\u7a76\u4eba\u54e1\u548c\u4f01\u696d\u5bb6\u751f\u614b\u7cfb\u7d71\u3002\u50cf\u9019\u6a23\u7684\u806f\u76df\u5c07\u5e6b\u52a9\u6211\u5011\u8d85\u8d8a\u50b3\u7d71\u88fd\u85e5\u884c\u696d\u7684\u904b\u71df\u6a21\u5f0f\uff0c\u64c1\u62b1\u91ab\u7642\u4fdd\u5065\u5275\u65b0\u7684\u672a\u4f86\uff0c\u5be6\u73fe\u6211\u5011\u91cd\u65b0\u60f3\u50cf\u91ab\u5b78\u4ee5\u9054\u5230\u6539\u5584\u548c\u5ef6\u9577\u58fd\u547d\u7684\u76ee\u7684\u3002\u201d<\/li>\n<\/ul>\n<h2><strong>Dragonfly<\/strong><strong>\u8207\u827e\u4f2f\u7dad\u5408\u4f5c\u6cbb\u7642\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u548c\u816b\u7624<\/strong><\/h2>\n<ul>\n<li>Dragonfly Therapeutics\u548c<a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=ABBV\">\u827e\u4f2f\u7dad(NYSE:ABBV)<\/a>\u5ba3\u4f48\u4e86\u4e00\u9805\u591a\u76ee\u6a19\u7814\u7a76\u5408\u4f5c\uff0c\u65e8\u5728\u63a8\u52d5\u8a31\u591aDragonfly\u57fa\u65bcNK\u7d30\u80de\u63a5\u5408\u5291\u7684\u514d\u75ab\u7642\u6cd5\u7528\u65bc\u81ea\u8eab\u514d\u75ab\u548c\u816b\u7624\u5b78\u9069\u61c9\u75c7\u3002<\/li>\n<li>\u901a\u904e\u6b64\u6b21\u5408\u4f5c\uff0c\u827e\u4f2f\u7dad\u53ef\u4ee5\u9078\u64c7\u7372\u5f97\u5168\u7403\u7368\u5bb6\u77e5\u8b58\u7522\u6b0a\u7684\u8a31\u53ef\uff0c\u4ee5\u958b\u767c\u548c\u5546\u696d\u5316\u91dd\u5c0d\u4f7f\u7528Dragonfly\u7684TriNKET\u6280\u8853\u5e73\u81fa\u958b\u767c\u7684\u7279\u5b9a\u6a19\u9776\u7522\u54c1\u3002<\/li>\n<li>\u827e\u4f2f\u7dad\u5c07\u652f\u4ed8\u9810\u4ed8\u6b3e\u3001\u91cc\u7a0b\u7891\u4ed8\u6b3e\u548c\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>In response to a challenge (opposition procedure), the European Patent Office has upheld the validity of Cellectis&#8217; (NASDAQ:CLLS) European Patent EP3004337 covering a method of preparing T cells for immunotherapy using the CRISPR\/Cas9 gene editing technology.<\/p>\n","protected":false},"author":9,"featured_media":268643,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,564],"class_list":["post-305730","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/305730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=305730"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/305730\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/268643"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=305730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=305730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=305730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}